David Baram: Founder and CEO of EmendoBio
Update: 2023-12-16
Description
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
